Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 70518-4563

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 70518-4563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Lurasidone HCl 20mg 70518 4563 00)

Lurasidone Hydrochloride 20 mg oral film-coated tablet packaging label from RemedyRepack Inc. The label indicates a quantity of 30 tablets, NDC number 70518-4563-00. It includes storage instructions (20-25°C with excursions to 15-30°C), a manufacturer info from Camber Pharma, Inc., and a QR code. The label states 'RX ONLY' and notes usual dosage information is in the insert.*

FDA Label Image

Lurasidonehclfig1 (Lurasidonehclfig1)

A horizontal error bar plot showing fold change and 90% confidence intervals for Cmax and AUC pharmacokinetic parameters of lurasidone when co-administered with interacting drugs: Ketoconazole (strong CYP3A4 inhibitor), Diltiazem (moderate CYP3A4 inhibitor), Rifampin (strong CYP3A4 inducer), and Lithium. The x-axis represents change relative to lurasidone alone, with values ranging approximately from -4 to 4 fold change.*

FDA Label Image

Lurasidonehclfig2 (Lurasidonehclfig2)

A forest plot chart showing fold change and 90% confidence intervals of pharmacokinetic parameters for various interacting drugs relative to the interactive drug alone. The chart includes data for substrates Digoxin 0.25 mg SD, Midazolam 5 mg SD, oral contraceptives Ethinyl Estradiol and Norelgestromin, and Lithium 600 mg BID, with values plotted along a horizontal axis from -1.0 to 1.0 change relative to interactive drug alone.*

FDA Label Image

Lurasidonehclfig3 (Lurasidonehclfig3)

A fold change and 90% confidence interval chart showing pharmacokinetic parameters Cmax and AUC for lurasidone hydrochloride under different conditions including renal impairment (mild, moderate, severe), hepatic impairment (mild, moderate, severe), and population descriptions by gender and race. The x-axis represents change relative to reference values, and the chart includes comparisons such as Asian versus Caucasian.*

FDA Label Image

Lurasidonehclstructure (Lurasidonehclstructure)

Chemical structure of lurasidone hydrochloride depicted as a detailed molecular diagram showing various rings and functional groups, including nitrogen, oxygen, sulfur, and hydrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.